Stories in this list received the most page views on SummitDaily.com from March 22-28. 1. US Postal Inspection Service conducting criminal investigation into Just Send It in Silverthorne The U.S.
Brockton Public Schools moved the last day of school and made two half days full days due to a blizzard of snow days this winter. Peter Colombo, former head football coach at Broc ...
Charlotte-based Easy Moving LLC broadens its local and long-distance moving capabilities for homes and businesses ...
There's one popular tequila brand that consistently outsells the rest in the United States, and the company has been around since the 1750s.
Braylon Mullins' 3-pointer with 0.4 seconds left gives UConn 73-72 win over Duke and Final Four spot
Braylon Mullins sank a desperation 3-pointer with 0.4 seconds left to give UConn an astonishing 73-72 victory over top-seeded Duke on Sunday, earning the Huskies a spot in the Final Four after they ...
Each week, syracuse.com will look back at some of our most important and valuable journalism from the previous week. Here are ...
Chief Operating Officer Patrick Barbeau said the company entered 2026 “in a very good position,” citing strong fundamentals, continued momentum in top-line growth, and market conditions that he ...
A top Iranian official has warned the U.S. against any ground invasion as regional diplomats met in Pakistan in a push to end the war ...
SportsGrid on MSN
Improving College Basketball Conference Performance
Smart scheduling and improved intra-league play significantly boosted the American Conference league's prestige. Commissioner Tim Pernetti discusses further.
Top diplomats from key regional powers gathered in Pakistan on Sunday to discuss how to end the fighting in the Middle East, but there were few signs of progress.
4hon MSN
Why BTIG Cut Its Target on Humacyte (HUMA) but Kept a Bullish View on the Bigger Opportunity
Humacyte, Inc. (NASDAQ:HUMA) is one of the penny stocks with potential to rise 1000 percent. On March 27, 2026, BTIG maintained its Buy rating on Humacyte but cut its price target to $3 from $6 after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results